
Toxicology Drug Screening Market by Product (Animal Models, Instruments, Reagents & Consumables), Testing (In Silico, In Vitro, In Vivo), Application - Global Forecast 2024-2030
Description
Toxicology Drug Screening Market by Product (Animal Models, Instruments, Reagents & Consumables), Testing (In Silico, In Vitro, In Vivo), Application - Global Forecast 2024-2030
The Toxicology Drug Screening Market size was estimated at USD 27.07 billion in 2023 and expected to reach USD 30.59 billion in 2024, at a CAGR 13.38% to reach USD 65.22 billion by 2030.
Global Toxicology Drug Screening Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Toxicology Drug Screening Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Toxicology Drug Screening Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Toxicology Drug Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International, Inc., Clinical Reference Laboratory, Inc., Enzo Life Sciences, Inc., Eurofins Scientific SE, GE Healthcare, Laboratory Corporation of America Holdings, Promega Corporation, Quest Diagnostics, Selvita S.A., Thermo Fisher Scientific Inc., Waters Corporation, and Wuxi AppTec Co., Ltd..
Market Segmentation & Coverage
This research report categorizes the Toxicology Drug Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Animal Models
Instruments
Reagents & Consumables
Software
Testing
In Silico
In Vitro
In Vivo
Application
Developmental & Reproductive Toxicity
Endocrine Disruption
Immunotoxicity
Systemictoxicity
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Toxicology Drug Screening Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Toxicology Drug Screening Market?
3. What are the technology trends and regulatory frameworks in the Toxicology Drug Screening Market?
4. What is the market share of the leading vendors in the Toxicology Drug Screening Market?
5. Which modes and strategic moves are suitable for entering the Toxicology Drug Screening Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
199 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Toxicology Drug Screening Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing practice of workplace drug testing and high penetration of point of care testing (POCT) devices
- 5.1.1.2. Growing availability of high-end drug screening instruments, reagent and kits
- 5.1.1.3. Rising government expenditure on toxicity testing
- 5.1.2. Restraints
- 5.1.2.1. High Cost of toxicology drug screening tests
- 5.1.3. Opportunities
- 5.1.3.1. Introduction of advanced toxicology drug screening tests
- 5.1.3.2. Rise in adoption of toxicology drug screening in the food and beverage industry, and chemical industry
- 5.1.4. Challenges
- 5.1.4.1. Longer time for sample testing associated with toxicology drug screening
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Toxicology Drug Screening Market, by Product
- 6.1. Introduction
- 6.2. Animal Models
- 6.3. Instruments
- 6.4. Reagents & Consumables
- 6.5. Software
- 7. Toxicology Drug Screening Market, by Testing
- 7.1. Introduction
- 7.2. In Silico
- 7.3. In Vitro
- 7.4. In Vivo
- 8. Toxicology Drug Screening Market, by Application
- 8.1. Introduction
- 8.2. Developmental & Reproductive Toxicity
- 8.3. Endocrine Disruption
- 8.4. Immunotoxicity
- 8.5. Systemictoxicity
- 9. Americas Toxicology Drug Screening Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Toxicology Drug Screening Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Toxicology Drug Screening Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Agilent Technologies, Inc.
- 13.1.3. Bio-Rad Laboratories Inc.
- 13.1.4. Charles River Laboratories International, Inc.
- 13.1.5. Clinical Reference Laboratory, Inc.
- 13.1.6. Enzo Life Sciences, Inc.
- 13.1.7. Eurofins Scientific SE
- 13.1.8. GE Healthcare
- 13.1.9. Laboratory Corporation of America Holdings
- 13.1.10. Promega Corporation
- 13.1.11. Quest Diagnostics
- 13.1.12. Selvita S.A.
- 13.1.13. Thermo Fisher Scientific Inc.
- 13.1.14. Waters Corporation
- 13.1.15. Wuxi AppTec Co., Ltd.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. TOXICOLOGY DRUG SCREENING MARKET RESEARCH PROCESS
- FIGURE 2. TOXICOLOGY DRUG SCREENING MARKET SIZE, 2023 VS 2030
- FIGURE 3. TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. TOXICOLOGY DRUG SCREENING MARKET DYNAMICS
- FIGURE 7. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2023 VS 2030 (%)
- FIGURE 10. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.